This podcast provides an in-depth exploration of type 2 inflammation and its role in the pathophysiology and management of atopic dermatitis, tailored for health plan professionals. Experts discuss the molecular mechanisms driving the condition, including key cytokines like IL-4 and IL-13, and highlight the clinical and quality-of-life impacts for patients. The conversation covers the evolution of targeted therapies, including biologics and JAK inhibitors, and emphasizes the importance of shared decision-making and timely treatment. Special attention is given to addressing health disparities in diagnosing and treating patients with darker skin tones, underscoring the need for equitable care strategies.

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at

https://www.impactedu.net/type2-inflammation-atopic-dermatitis-management.